Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$48.3 - $68.06 $45,063 - $63,499
933 Added 28.88%
4,164 $270,000
Q3 2023

Nov 13, 2023

BUY
$54.2 - $71.67 $175,120 - $231,565
3,231 New
3,231 $211,000
Q3 2022

Nov 07, 2022

SELL
$65.58 - $84.69 $195,690 - $252,714
-2,984 Reduced 50.39%
2,938 $213,000
Q2 2022

Aug 08, 2022

SELL
$52.13 - $93.81 $128,291 - $230,866
-2,461 Reduced 29.36%
5,922 $403,000
Q1 2022

May 10, 2022

BUY
$64.92 - $99.47 $306,941 - $470,294
4,728 Added 129.36%
8,383 $760,000
Q4 2021

Feb 11, 2022

BUY
$76.51 - $93.96 $279,644 - $343,423
3,655 New
3,655 $334,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $4.24B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.